Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:P33527 (
ABCC1
)
1,164
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Glutathione (GSH) plays numerous critical protective roles in the erythrocyte and GSH turnover is likely an important factor in regulating susceptibility to oxidative stress and toxins. Efflux of glutathione disulfide (GSSG) from erythrocytes is an important component in the regulation of GSH levels; however, little is known of the mechanisms involved. We hypothesize that
multidrug resistance associated protein 1
(
MRP1
) is responsible, in part, for GSSG transport from erythrocytes. To test this, we determined the levels of
MRP1
protein in erythrocyte membranes from healthy adults and compared them with intracellular levels of GSH.
MRP1
levels varied substantially from person to person and were inversely correlated with levels of GSH (r = -0.39, P < 0.05). In contrast, activity levels of glutamyl cysteine ligase, the rate limiting GSH biosynthetic enzyme, were unrelated to GSH levels. To directly determine the role of
MRP1
in GSSG transport, in vitro studies were conducted examining the effects of
MRP1
inhibitors MK571 and verapamil on GSSG efflux. Both compounds resulted in significant but not complete inhibition (20-53%) of GSSG efflux from cells. Overall, these findings support a role for
MPR1
in the regulation of erythrocyte GSH levels through the transport and elimination of GSSG from cells.
...
PMID:Mechanisms of glutathione disulfide efflux from erythrocytes. 2196 44